Discover

OMER
Omeros Corporation
18.44
2 x 9.39
2 x 16.29
bid
ask
-
0.51
2.69%
2 @ 05:17 PM
17.99 -0.45 (2.42%)
Ytd7.33%
1y145.21%
18.05
day range
19.01
6.24
52 week range
21.24
Open18.53Prev Close18.95Low18.05High19.01Mkt Cap1.33B
Vol885.58KAvg Vol1.68MEPS1.22P/E15.11Forward P/E14.99
Beta2.57Short Ratio8.63Inst. Own51.52%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-1250-d Avg18.52200-d Avg13.461yr Est27.50

OMER News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation

NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation

NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation

NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

Omeros (NASDAQ:OMER) Shares Gap Down – Here’s Why
defenseworld.net
Omeros (NASDAQ:OMER) Shares Gap Down – Here’s Why

Omeros Corporation (NASDAQ: OMER - Get Free Report)'s share price gapped down before the market open

benzinga.com
Truist Financial, Regions Financial And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. stock futures mixed; Truist slips after mixed results, while Telkom Indonesia, Loma Negra, Omer

Omeros Stock Sinks on Negative EU Opinion for Narsoplimab, Compassionate-Use Program Ends
benzinga.com
Omeros Stock Sinks on Negative EU Opinion for Narsoplimab, Compassionate-Use Program Ends

Omeros Corporation (NASDAQ:OMER) shares are trading lower Friday after the company announced that th

Omeros Stock Sinks on Negative EU Opinion for Narsoplimab, Compassionate-Use Program Ends
benzinga.com
Omeros Stock Sinks on Negative EU Opinion for Narsoplimab, Compassionate-Use Program Ends

Omeros shares are trading lower Friday after the company announced that the EMA’s CHMP upheld its ne

benzinga.com
Omeros Receives EMA CHMP Negative Opinion On Its Marketing Authorization Application For Narsoplimab

Decision follows re-examination of its original negative opinion adopted in June 2026. An eight-memb

Omeros Corporation Receives CHMP Negative Opinion Following Re-Examination of European Marketing Authorization Application for Narsoplimab in TA-TMA
businesswire.com
Omeros Corporation Receives CHMP Negative Opinion Following Re-Examination of European Marketing Aut

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced that the Committee for M

benzinga.com
Cantor Fitzgerald Reiterates Overweight on Omeros, Maintains $22 Price Target

Cantor Fitzgerald analyst Olivia Brayer Saunders reiterates Omeros (NASDAQ:OMER) with a Overweigh

This 3M Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday
benzinga.com
This 3M Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday

Analysts upgraded First Financial, 3M, Synopsys, Humana and Stem, raising targets for four while mai

Omeros (NASDAQ:OMER) Hits New 1-Year High  – Should You Buy?
defenseworld.net
Omeros (NASDAQ:OMER) Hits New 1-Year High – Should You Buy?

Shares of Omeros Corporation (NASDAQ: OMER - Get Free Report) reached a new 52-week high during mid-

Omeros Transplant Drug Could Be Bigger than Expected, Says Analyst
benzinga.com
Omeros Transplant Drug Could Be Bigger than Expected, Says Analyst

Cantor Fitzgerald on Tuesday upgraded Omeros Corp (NASDAQ:OMER), citing a better-than-expected Yarte

Omeros Transplant Drug Could Be Bigger than Expected, Says Analyst
benzinga.com
Omeros Transplant Drug Could Be Bigger than Expected, Says Analyst

Cantor upgrades Omeros to Overweight with a $22 price forecast following strong Yartemlea sales and

On Holding, Viking Therapeutics, Shopify And Other Big Stocks Moving Higher On Tuesday
benzinga.com
On Holding, Viking Therapeutics, Shopify And Other Big Stocks Moving Higher On Tuesday

U.S. stocks rose, led by On Holding's 13% surge after strong guidance and a $1B buyback; Viking

This Plexus Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
benzinga.com
This Plexus Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Analysts upgraded MetLife, Brinker, Plexus, West Pharma and Omeros, raising ratings and price target

benzinga.com
Cantor Fitzgerald Upgrades Omeros to Overweight, Announces $22 Price Target

Cantor Fitzgerald analyst Olivia Brayer Saunders upgrades Omeros (NASDAQ:OMER) from Neutral to Ov

Reviewing Omeros (NASDAQ:OMER) & Ligand Pharmaceuticals (NASDAQ:LGND)
defenseworld.net
Reviewing Omeros (NASDAQ:OMER) & Ligand Pharmaceuticals (NASDAQ:LGND)

Omeros (NASDAQ: OMER - Get Free Report) and Ligand Pharmaceuticals (NASDAQ: LGND - Get Free Report)

BlackRock Inc. Invests $57.48 Million in Omeros Corporation $OMER
defenseworld.net
BlackRock Inc. Invests $57.48 Million in Omeros Corporation $OMER

BlackRock Inc. purchased a new stake in Omeros Corporation (NASDAQ: OMER) in the second quarter, acc

What Makes Omeros (OMER) a Strong Momentum Stock: Buy Now?
zacks.com
What Makes Omeros (OMER) a Strong Momentum Stock: Buy Now?

Does Omeros (OMER) have what it takes to be a top stock pick for momentum investors? Let's find out.

Omeros (OMER) Just Flashed Golden Cross Signal: Do You Buy?
zacks.com
Omeros (OMER) Just Flashed Golden Cross Signal: Do You Buy?

Omeros Corporation (OMER) is looking like an interesting pick from a technical perspective, as the c

Omeros Corporation (NASDAQ:OMER) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
defenseworld.net
Omeros Corporation (NASDAQ:OMER) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of Omeros Corporation (NASDAQ: OMER - Get Free Report) have been given an average recommendat

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Liminatus Pharma (NASDAQ:LIMN) stock increased by 48.4% to $0.16 during Thursday's regu

Accelerant Holdings, CorMedix, Birkenstock And Other Big Stocks Moving Higher On Thursday
benzinga.com
Accelerant Holdings, CorMedix, Birkenstock And Other Big Stocks Moving Higher On Thursday

Nasdaq Composite gained 200 points on Thursday, while Accelerant Holdings (NYSE: ARX) rose 44.2% af

12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.9% to $0.17 during Thursday's

Why Omeros Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Omeros Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket

Omeros Corp (OMER) shares rose 17.2% in pre-market trading after reporting better-than-expected Q2 r

Omeros Corporation (OMER) Q2 2026 Earnings Call Transcript
seekingalpha.com
Omeros Corporation (OMER) Q2 2026 Earnings Call Transcript

Omeros Corporation (OMER) Q2 2026 Earnings Call Transcript

Omeros Q2 Earnings Call Highlights
marketbeat.com
Omeros Q2 Earnings Call Highlights

Omeros NASDAQ: OMER reported second-quarter net sales of $28.5 million for YARTEMLEA, its newly laun

Omeros (OMER) Q2 Earnings and Revenues Beat Estimates
zacks.com
Omeros (OMER) Q2 Earnings and Revenues Beat Estimates

Omeros (OMER) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estim

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers ENvue Medical (NASDAQ:FEED) shares rose 49.1% to $0.61 during Wednesday's after-market

benzinga.com
Omeros Q2 Adj. EPS $0.02 Beats $(0.27) Estimate, Sales $28.529M Beat $12.700M Estimate

Omeros (NASDAQ:OMER) reported quarterly earnings of $0.02 per share which beat the analyst consensus

Omeros Corporation Reports Second Quarter 2026 Financial Results
businesswire.com
Omeros Corporation Reports Second Quarter 2026 Financial Results

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced recent highlights and de

Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026
businesswire.com
Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that it will issue its f

Omeros (NASDAQ:OMER) Shares Pass Above Two Hundred Day Moving Average   – Here’s What Happened
defenseworld.net
Omeros (NASDAQ:OMER) Shares Pass Above Two Hundred Day Moving Average – Here’s What Happened

Shares of Omeros Corporation (NASDAQ: OMER - Get Free Report) crossed above its two hundred day movi

Baker Hughes Posts Upbeat Q2 Earnings, Joins Forte Biosciences, Eikon Therapeutics And Other Big Stocks Moving Higher On Monday
benzinga.com
Baker Hughes Posts Upbeat Q2 Earnings, Joins Forte Biosciences, Eikon Therapeutics And Other Big Sto

Dow Jones up 400 points on Monday. Baker Hughes Co (BKR) shares rise after positive earnings and tec

Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
benzinga.com
Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

US stock futures up, Nasdaq 100 gains 1%. Biohaven (BHVN) shares down after BofA downgrade and enrol

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

Gainers INVO Fertility (NASDAQ:IVF) shares moved upwards by 67.3% to $2.08 during Friday's regu

Crude Oil Falls 4%; US Consumer Sentiment Rises In June
benzinga.com
Crude Oil Falls 4%; US Consumer Sentiment Rises In June

U.S. stocks slightly up, Dow Jones gains 0.1%. Health care shares jump 2.8%, ON Semiconductor down 2

benzinga.com
HC Wainwright & Co. Maintains Buy on Omeros, Lowers Price Target to $33

HC Wainwright & Co. analyst Brandon Folkes maintains Omeros (NASDAQ:OMER) with a Buy and lowe

FDA Approved, Europe Unconvinced: Omeros' Stem Cell Transplant Treatment Hits Regulatory Divide
benzinga.com
FDA Approved, Europe Unconvinced: Omeros' Stem Cell Transplant Treatment Hits Regulatory Divide

EMA rejects Omeros' Yartemlea for TA-TMA, citing insufficient efficacy data, despite FDA approva

benzinga.com
Omeros Gets EMA CHMP Negative Opinion On Narsoplimab In TA‑TMA; Co. To Request Re‑Examination And Se

Omeros Corporation (NASDAQ:OMER) announced today an update on the review by the Committee for Medici

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers Quantum Cyber (NASDAQ:QUCY) stock moved upwards by 63.4% to $2.37 during Friday's pre-m

ON Semiconductor, SanDisk And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
benzinga.com
ON Semiconductor, SanDisk And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. stock futures down, Nasdaq 100 futures drop over 1%. ON Semi to acquire Synaptics, ON shares fa

benzinga.com
HC Wainwright & Co. Reiterates Buy on Omeros, Maintains $40 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Omeros (NASDAQ:OMER) with a Buy and mai

benzinga.com
HC Wainwright & Co. Reiterates Buy on Omeros, Maintains $40 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Omeros (NASDAQ:OMER) with a Buy and mai

benzinga.com
Omeros Q1 Adj. EPS $(0.24) Beats $(0.32) Estimate, Sales $9.893M Miss $10.125M Estimate

Omeros (NASDAQ:OMER) reported quarterly losses of $(0.24) per share which beat the analyst consensus

Earnings Scheduled For May 13, 2026
benzinga.com
Earnings Scheduled For May 13, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

Earnings Scheduled For March 31, 2026
benzinga.com
Earnings Scheduled For March 31, 2026